Highlights
NASDAQ: IDXG       Interpace Diag Grp
Last Price Today's Change   Day's Range   Trading Volume
1.22   +0.01 (0.83%)  1.18 - 1.25  714,500

Overview

 
Avg Volume (4 weeks):956,710
4 Weeks Range:1.10 - 1.40
4 Weeks Price Volatility (%):
40.00%
52 Weeks Range:0.07 - 14.25
52 Weeks Price Volatility (%):
8.11%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Interpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, the Company provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.

  Be the first to like this.
 


 

4846  2447  754  419 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SPY 257.86-0.76 
 INTC 44.63-1.02 
 GE 18.21-0.04 
 AMD 11.38+0.13 
 BAC 26.62-0.14 
 EEM 46.82+0.23 
 XLF 26.16-0.03 
 TEVA 13.84+1.05 
 SQ 44.18+2.28 
 VXX 34.45-0.56 
Partners & Brokers